Ayrmid Unveils Promising Data on Motixafortide for Rare Blood Disorders
Ayrmid has announced significant new findings regarding the use of motixafortide for mobilizing hematopoietic stem cells (HSCs) in patients suffering from sickle cell disease and beta-thalassemia. These results, presented at…